Long COVID: A Comprehensive Overview of the Signs and Symptoms across Multiple Organ Systems
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Long coronavirus disease (COVID), also known as the post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC), is a significant concern since the end of the COVID-19 pandemic, as it still manifests in individuals with persistent symptoms and complications beyond the acute phase of infection. Defining this disease is challenging, as it manifests as a spectrum of symptoms varying in severity among individuals who have previously tested positive for COVID-19. Long COVID is more prevalent in hospitalized COVID-19 patients and presents in various ways, ranging from pulmonary to extrapulmonary symptoms. This literature review examines the current body of research on long COVID with a focus on its effects on the cardiovascular, hematological, respiratory, renal, and neurological systems with systematically analyzed, peer-reviewed articles retrieved from the PubMed database. There have been several proposed pathophysiological mechanisms by which severe acute respiratory syndrome coronavirus 2 affects the aforementioned organ systems; however, research on the definite mechanisms is lacking, especially when considering the management of long COVID in the perioperative setting. The impact of post-COVID sequelae necessitates individualized management strategies tailored to each symptomatic profile, particularly in patients with comorbidities. The COVID-19 pandemic affected millions of people and had a profound impact on those who developed PASC, lowering their quality of life and increasing potential surgical risks. However, there is still uncertainty regarding the specific risk factors for long COVID and who is most susceptible to it. Further research is required to fill these gaps and explore potential avenues for preventing PASC.
Abstract
Long coronavirus disease (COVID), also known as the post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC), is a significant concern since the end of the COVID-19 pandemic, as it still manifests in individuals with persistent symptoms and complications beyond the acute phase of infection. Defining this disease is challenging, as it manifests as a spectrum of symptoms varying in severity among individuals who have previously tested positive for COVID-19. Long COVID is more prevalent in hospitalized COVID-19 patients and presents in various ways, ranging from pulmonary to extrapulmonary symptoms. This literature review examines the current body of research on long COVID with a focus on its effects on the cardiovascular, hematological, respiratory, renal, and neurological systems with systematically analyzed, peer-reviewed articles retrieved from the PubMed database. There have been several proposed pathophysiological mechanisms by which severe acute respiratory syndrome coronavirus 2 affects the aforementioned organ systems; however, research on the definite mechanisms is lacking, especially when considering the management of long COVID in the perioperative setting. The impact of post-COVID sequelae necessitates individualized management strategies tailored to each symptomatic profile, particularly in patients with comorbidities. The COVID-19 pandemic affected millions of people and had a profound impact on those who developed PASC, lowering their quality of life and increasing potential surgical risks. However, there is still uncertainty regarding the specific risk factors for long COVID and who is most susceptible to it. Further research is required to fill these gaps and explore potential avenues for preventing PASC.
참고문헌 (73)
- Yang C, "Association of SARS-CoV-2 infection and persistence with long COVID", Lancet Respir Med, 11, pp.504~506 (2023)
- Gonzalez-Garcia P, "From cell to symptoms : the role of SARS-CoV-2 cytopathic effects in the pathogenesis of COVID-19 and long COVID", Int J Mol Sci, 24, pp.8290~ (2023)
- Kenny G, "Long COVID : clinical characteristics, proposed pathogenesis and potential therapeutic targets", Front Mol Biosci, 10, pp.1157651~ (2023)
- Pavli A, "Post-COVID syndrome : incidence, clinical spectrum, and challenges for primary healthcare professionals", Arch Med Res, 52, pp.575~581 (2021)
- O’Mahoney LL, "The prevalence and long-term health effects of long COVID among hospitalised and non-hospitalised populations : a systematic review and meta-analysis", EClinicalMedicine, 55, pp.101762~ (2022)
- Magnavita N, "Post-COVID symptoms in occupational cohorts : effects on health and work ability", Int J Environ Res Public Health, 20, pp.5638~ (2023)
- Roever L, "Long-term consequences of COVID-19 on mental health and the impact of a physically active lifestyle : a narrative review", Ann Gen Psychiatry, 22, pp.19~ (2023)
- Chen TH, "Possible pathogenesis and prevention of long COVID : SARS-CoV-2-induced mitochondrial disorder", Int J Mol Sci, 24, pp.8034~ (2023)
- Xie Y, "Long-term cardiovascular outcomes of COVID-19", Nat Med, 28, pp.583~590 (2022)
- Konig BH, "Prognostic factors for persistent fatigue after COVID-19 : a prospective matched cohort study in primary care", Br J Gen Pract, 73, pp.e340~e347 (2023)
- Yu Z, "Ambient air pollution exposure linked to long COVID among young adults : a nested survey in a population-based cohort in Sweden", Lancet Reg Health Eur, 28, pp.100608~ (2023)
- Morello R, "Risk factors for post-COVID-19 condition(long COVID)in children : a prospective cohort study", EClinicalMedicine, 59, pp.101961~ (2023)
- Yasmin F, "Adverse events following COVID-19 mRNA vaccines : a systematic review of cardiovascular complication, thrombosis, and thrombocytopenia", Immun Inflamm Dis, 11, pp.e807~ (2023)
- Mirnia K, "Short-term side effects of COVID-19 vaccines among healthcare workers : a multicenter study in Iran", Sci Rep, 14, pp.4086~ (2024)
- Bostanci A, "Long-COVID-19 in asymptomatic, non-hospitalized, and hospitalized populations : a cross-sectional study", J Clin Med, 12, pp.2613~ (2023)
- Arnold DT, "Symptoms after COVID-19 vaccination in patients with persistent symptoms after acute infection : a case series", Ann Intern Med, 174, pp.1334~1336 (2021)
- Ayoubkhani D, "Trajectory of long COVID symptoms after COVID-19vaccination : community based cohort study", BMJ, 377, pp.e069676~ (2022)
- Bergmans RS, "‘I’m still here, I’m alive and breathing’ : the experience of Black Americans with long COVID", J Clin Nurs, 33, pp.162~177 (2024)
- Hua MJ, "Prevalence and characteristics of long COVID 7-12 months after hospitalization among patients from an urban safety-net hospital : a pilot study", AJPM Focus, 2, pp.100091~ (2023)
- Fukushima H, "The sustained psychological impact of coronavirus disease 2019 pandemic on hospital workers 2 years after the outbreak : a repeated crosssectional study in Kobe", BMC Psychiatry, 23, pp.313~ (2023)
- Parhizgar P, "Beyond acute COVID-19 : a review of long-term cardiovascular outcomes", Can J Cardiol, 39, pp.726~740 (2023)
- "Long COVID in adults: United States, 2022" (2023)[URL]
- Bhatt VR, "Post-COVID multisystem inflammatory syndrome-adult leading to cardiomyopathy and autoimmune thyroiditis : a case report", Cureus, 15, pp.e33754~ (2023)
- Abbasi J, "The COVID heart-one year after SARS-CoV-2 infection, patients have an array of increased cardiovascular risks", JAMA, 327, pp.1113~1114 (2022)
- Daines L, "A clinical review of long-COVID with a focus on the respiratory system", Curr Opin Pulm Med, 28, pp.174~179 (2022)
- Pretorius E, "Persistent clotting protein pathology in long COVID", post-acute sequelae of COVID-19(PASC)is accompanied by increased levels of antiplasmin, 2021, pp.20, 172~
- Seshadri M, "Intervention in COVID-19 linked hypercoaguable states characterized by circuit thrombosis utilizing a direct thrombin inhibitor", Thromb Update, 1, pp.100009~ (2020)
- Cushman M, "Epidemiology and risk factors for venous thrombosis", Semin Hematol, 44, pp.62~69 (2007)
- Hajra A, "Management of thrombotic complications in COVID-19 : an update", Drugs, 80, pp.1553~1562 (2020)
- Abou-Ismail MY, "The hypercoagulable state in COVID-19 : incidence, pathophysiology, and management", Thromb Res, 194, pp.101~115 (2020)
- Varga Z, "Endothelial cell infection and endotheliitis in COVID-19", Lancet, 395, pp.1417~1418 (2020)
- Iba T, "The unique characteristics of COVID-19 coagulopathy", Crit Care, 24, pp.360~ (2020)
- Dixit NM, "Post-acute COVID-19 syndrome and the cardiovascular system : what is known?", Am Heart J Plus, 5, pp.100025~ (2021)
- Cares-Marambio K, "Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019(COVID-19) : a systematic review and meta-analysis", Chron Respir Dis, 18, pp.14799731211002240~ (2021)
- Becker RC, "Evaluating chest pain in patients with post COVID conditions permission to think outside of the box", J Thromb Thrombolysis, 55, pp.592~603 (2023)
- Shi S, "Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China", JAMA Cardiol, 5, pp.802~810 (2020)
- Rohun J, "Long COVID-19 myocarditis and various heart failure presentations : a case series", J Cardiovasc Dev Dis, 9, pp.427~ (2022)
- Knight DS, "COVID-19 : myocardial injury in survivors", Circulation, 142, pp.1120~1122 (2020)
- Melchior SE, "Recurring episodes of bundle branch reentry ventricular tachycardia due to aortitis preceded by SARS-CoV-2 infection : a case report", BMC Cardiovasc Disord, 23, pp.46~ (2023)
- Qamar MA, "A global systematic review and meta-analysis on the emerging evidence on risk factors, clinical characteristics, and prognosis of multisystem inflammatory syndrome in adults(MIS-A)", Ann Med Surg(Lond), 85, pp.4463~4475 (2023)
- Diekman S, "Post-acute sequelae of SARS-CoV-2 syndrome presenting as postural orthostatic tachycardia syndrome", Clin Exp Emerg Med, 10, pp.18~25 (2023)
- Yates T, "Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance(NAVIGATOR trial) : a cohort analysis", Lancet, 383, pp.1059~1066 (2014)
- Stavrou VT, "Eight weeks unsupervised pulmonary rehabilitation in previously hospitalized of SARS-CoV-2 infection", J Pers Med, 11, pp.806~ (2021)
- Tang Y, "Liuzijue is a promising exercise option for rehabilitating discharged COVID-19 patients", Medicine(Baltimore), 100, pp.e24564~ (2021)
- Raj SR, "Canadian Cardiovascular Society position statement on postural orthostatic tachycardia syndrome(POTS)and related disorders of chronic orthostatic intolerance", Can J Cardiol, 36, pp.357~372 (2020)
- Tian S, "Pathological study of the 2019 novel coronavirus disease(COVID-19)through postmortem core biopsies", Mod Pathol, 33, pp.1007~1014 (2020)
- Leung TY, "Short-and potential long-term adverse health outcomes of COVID-19 : a rapid review", Emerg Microbes Infect, 9, pp.2190~2199 (2020)
- Yan Z, "Long COVID-19 syndrome : a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans", Biomedicines, 9, pp.966~ (2021)
- Wang F, "Long-term respiratory and neurological sequelae of COVID-19", Med Sci Monit, 26, pp.e928996~ (2020)
- PHOSP-COVID Collaborative Group, "Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK : a prospective observational study", Lancet Respir Med, 10, pp.761~775 (2022)
- Chippa V, "Postacute coronavirus (COVID-19) syndrome" (2024), StatPearls Publishing
- Huang L, "1-year outcomes in hospital survivors with COVID-19 : a longitudinal cohort study", Lancet, 398, pp.747~758 (2021)
- Song WJ, "Confronting COVID-19-associated cough and the post-COVID syndrome : role of viral neurotropism, neuroinflammation, and neuroimmune responses", Lancet Respir Med, 9, pp.533~544 (2021)
- Stavem K, "Persistent symptoms 1. 5-6 months after COVID-19 in non-hospitalised subjects : a population-based cohort study", Thorax, 76, pp.405~407 (2021)
- Bowe B, "Kidney outcomes in long COVID", J Am Soc Nephrol, 32, pp.2851~2862 (2021)
- Al-Aly Z, "Long COVID : long-term health outcomes and implications for policy and research", Nat Rev Nephrol, 19, pp.1~2 (2023)
- Copur S, "Post-acute COVID-19 syndrome and kidney diseases : what do we know?", J Nephrol, 35, pp.795~805 (2022)
- Legrand M, "Pathophysiology of COVID-19-associated acute kidney injury", Nat Rev Nephrol, 17, pp.751~764 (2021)
- Głowacka M, "Acute kidney injury in COVID-19", Int J Mol Sci, 22, pp.8081~ (2021)
- Atiquzzaman M, "Long-term effect of COVID-19 infection on kidney function among COVID-19 patients followed in post-COVID-19 recovery clinics in British Columbia, Canada", Nephrol Dial Transplant, 38, pp.2816~2825 (2023)
- Martin de Francisco A, "Long COVID-19 renal disease : a present medical need for nephrology", Nefrologia(Engl Ed), 43, pp.1~5 (2023)
- Schiffl H, "Long-term interplay between COVID-19 and chronic kidney disease", Int Urol Nephrol, 55, pp.1977~1984 (2023)
- Li D, "Clinical status of patients 1 year after hospital discharge following recovery from COVID-19 : a prospective cohort study", Ann Intensive Care, 12, pp.64~ (2022)
- Yende S, "Long COVID and kidney disease", Nat Rev Nephrol, 17, pp.792~793 (2021)
- Monje M, "The neurobiology of long COVID", Neuron, 110, pp.3484~3496 (2022)
- Reiss AB, "Long COVID, the brain, nerves, and cognitive function", Neurol Int, 15, pp.821~841 (2023)
- Zhao S, "Effects of COVID-19 on cognition and brain health", Trends Cogn Sci, 27, pp.1053~1067 (2023)
- Volk P, "Long-term neurological dysfunction associated with COVID-19 : lessons from influenza and inflammatory diseases?", J Neurochem, 168, pp.3500~3511 (2024)
- Asadi-Pooya AA, "Long COVID syndrome-associated brain fog", J Med Virol, 94, pp.979~984 (2022)
- Granholm AC, "Long-term effects of SARS-CoV-2 in the brain : clinical consequences and molecular mechanisms", J Clin Med, 12, pp.3190~ (2023)
- Oronsky B, "A review of persistent post-COVID syndrome(PPCS)", Clin Rev Allergy Immunol, 64, pp.66~74 (2023)
- Watanabe A, "Protective effect of COVID-19 vaccination against long COVID syndrome : a systematic review and meta-analysis", Vaccine, 41, pp.1783~1790 (2023)
- Malesevic S, "Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19", Sci Rep, 13, pp.7717~ (2023)